Abnormal Platelet miRNA Profile Associated with Endometriosis

In: Nanoscience and Nanotechnology Letters · 2020 · vol. 12(7) , pp. 863–873 · doi:10.1166/nnl.2020.3184 · W3119964091
article OA: closed CC0
View on OpenAlex View at publisher
AI-generated summary by claude@2026-06, 2026-06-08

This study identified abnormal expression of miR-542-3p and miR-618 in platelets of endometriosis patients, finding they target CCND2, a potential diagnostic biomarker.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Endometriosis (EM) is a condition characterized by the growth of functional endometrium in areas other than the uterus. In this study, microRNAs (miRNAs) were extracted from peripheral blood platelets from patients diagnosed with EM and from healthy controls for high-throughput sequencing; differential expression of miR-542-3p and miR-618 was identified via database comparisons. Dual pathway enrichment analysis revealed that both miRNAs may target the cyclin protein, G1/S-specific cyclin-D2 (CCND2). CCND2 was verified as a target gene of both miR-542-3p and miR-618 via experiments carried out in vivo . Taken together, these results reveal that CCND2 may serve as a functional biomarker for the diagnosis of EM.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK